KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Operating Expenses (2017 - 2025)

Cardlytics' Operating Expenses history spans 9 years, with the latest figure at $62.2 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 24.45% year-over-year to $62.2 million; the TTM value through Dec 2025 reached $335.1 million, down 29.28%, while the annual FY2025 figure was $335.1 million, 29.28% down from the prior year.
  • Operating Expenses reached $62.2 million in Q4 2025 per CDLX's latest filing, down from $120.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $465.1 million in Q4 2022 to a low of $32.3 million in Q1 2022.
  • Average Operating Expenses over 5 years is $120.0 million, with a median of $95.0 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: surged 336.92% in 2022, then tumbled 58.7% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $106.5 million in 2021, then soared by 336.92% to $465.1 million in 2022, then crashed by 58.7% to $192.1 million in 2023, then plummeted by 57.15% to $82.3 million in 2024, then dropped by 24.45% to $62.2 million in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Operating Expenses are $62.2 million (Q4 2025), $120.9 million (Q3 2025), and $76.0 million (Q2 2025).